ACIU
AC Immune Ltd
2.60$
+2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -109.4% | 149.1% | 10,629.8% | -55.5% | 521.9% | -1,900.6% | -1,194.3% | -1,953.1% | -4,866.2% | – | – | – | |
| – | 3.7% | 80.9% | 79.8% | 2.1% | 46.5% | 61.8% | 47.7% | 65.3% | 192.3% | – | – | – | |
| – | 5.4% | 273.9% | 88.5% | 4.8% | 85.0% | 157.4% | 85.8% | 86.6% | 267.5% | – | 17.4% | – | |
| – | -98.8% | 2,636.4% | 13,278.5% | -94.9% | 1,966.6% | -231.9% | 116.5% | -10.5% | -1,116.2% | – | – | – | |
| – | 1.1% | 36.2% | 9.9% | 0.7% | 7.9% | 36.6% | 28.6% | 6.2% | 31.7% | 0.0% | 0.0% | 0.9% | |
| – | 157.3% | -3,429.5% | -11,035.8% | -8.2% | -336.5% | 305.9% | 1,828.7% | 2,196.8% | 4,716.0% | – | – | – | |
| – | – | – | – | – | – | -0.5% | – | – | – | – | – | – | |
| – | – | – | – | -0.7% | -15.0% | -25.6% | -19.5% | -27.5% | -76.9% | – | – | – | |
| – | 277.2% | -100.1% | -9.0% | -0.7% | -17.3% | -26.1% | -18.9% | -27.1% | -76.9% | – | – | – | |
| – | 314.6% | -3,127.4% | -792.6% | -75.1% | 339.3% | -1,648.0% | 441.2% | 215.0% | -245.1% | -890.6% | – | – | |
| – | -110.5% | 112.8% | 10,619.9% | -56.2% | 514.0% | -1,937.2% | -1,222.9% | -1,959.3% | -4,897.9% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.